New Partnership Announcement signs Partnerships with Two German Companies
Partnerships 27.04.2023

We enter into two more Partnerships with German Companies

Strategic partnership of

We are excited to announce two new partnerships with and CeBioLabs. The companies Mertz Pharma Handel GmbH and the public limited company THE JOLLY HOUSE AG will work closely with

Mertz Pharma Handel GmbH and THE JOLLY HOUSE AG

CeBioLabs and the new project have already established numerous partnerships with German and international companies. We will publish and announce these over time. Today we would like to announce two partnerships: Mertz Pharma Handel GmbH and THE JOLLY HOUSE AG.

Mertz Pharma Handel GmbH

Founded in 2011, this pharmaceutical trading company based in Hamburg, Germany, trades pharmaceuticals worldwide. With years of experience and a large network, Metz Pharma Handel is one of the major players in this field. The company has applied for a license to trade in narcotics, i.e. medical cannabis, which should be issued in the coming weeks or months. Since the company deals with pharmaceuticals and other products that must have laboratory analysis, Mertz Pharma Handel will use our service on for various, worldwide analyses. In addition, will also be used by Mertz Pharma Handel in Africa, which will open up a new market for us.


The joint stock company THE JOLLY HOUSE from Hamburg is one of the established wholesalers in Germany in the field of food supplements, especially CBD oils, cosmetics and other products. With a wide range of products and numerous distributors THE JOLLY HOUSE is one of the new customers of The company will secure numerous analytics via our platform in the blockchain and not only use them themselves, but also make them available to retailers.

Benefits for

The two new partnerships with Mertz Pharma Handel and THE JOLLY HOUSE will expand’s customer base. Not only will we receive many lab analyses from the two companies and add them to the blockchain, but we will also gain new additional partners, especially abroad, such as Africa and other countries. New resulting partnerships with labs and large companies will significantly accelerate the growth of and bring great benefits to CeBioLabs.